Abstract
Stroke is the second-leading cause of death and a leading cause of serious long-term disability worldwide, with an increasing global burden due to the growing and aging population. However, strict eligibility criteria for current treatment opportunities make novel therapeutic approaches desirable. Oxidative stress plays a pivotal role during cerebral ischemia, eventually leading to neuronal injury and cell death. The significant correlation between redox imbalance and ischemic stroke has led to various treatment strategies targeting the endogenous antioxidant system in order to ameliorate the adverse prognosis in patients with cerebral infarction. One of the most extensively investigated cellular defense pathway in this regard is the Nrf2-heme oxygenase-1 (HO-1) axis. In this review, our aim is to focus on the potential clinical relevance of targeting the HO-1 pathway in ischemic stroke.
Keywords: Ischemic stroke, oxidative stress, heme oxygenase-1, cerebral ischemia, cerebral infarction, antioxidant system.
Current Pharmaceutical Design
Title:Heme Oxygenase-1: Clinical Relevance in Ischemic Stroke
Volume: 24 Issue: 20
Author(s): Daniel Bereczki Jr.*, Jozsef Balla and Daniel Bereczki
Affiliation:
- Department of Neurology, Medical Centre, Hungarian Defence Forces, Budapest,Hungary
Keywords: Ischemic stroke, oxidative stress, heme oxygenase-1, cerebral ischemia, cerebral infarction, antioxidant system.
Abstract: Stroke is the second-leading cause of death and a leading cause of serious long-term disability worldwide, with an increasing global burden due to the growing and aging population. However, strict eligibility criteria for current treatment opportunities make novel therapeutic approaches desirable. Oxidative stress plays a pivotal role during cerebral ischemia, eventually leading to neuronal injury and cell death. The significant correlation between redox imbalance and ischemic stroke has led to various treatment strategies targeting the endogenous antioxidant system in order to ameliorate the adverse prognosis in patients with cerebral infarction. One of the most extensively investigated cellular defense pathway in this regard is the Nrf2-heme oxygenase-1 (HO-1) axis. In this review, our aim is to focus on the potential clinical relevance of targeting the HO-1 pathway in ischemic stroke.
Export Options
About this article
Cite this article as:
Bereczki Jr. Daniel *, Balla Jozsef and Bereczki Daniel , Heme Oxygenase-1: Clinical Relevance in Ischemic Stroke, Current Pharmaceutical Design 2018; 24 (20) . https://dx.doi.org/10.2174/1381612824666180717101104
DOI https://dx.doi.org/10.2174/1381612824666180717101104 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Updated Role of Nitric Oxide in Disorders of Erythrocyte Function
Cardiovascular & Hematological Disorders-Drug Targets Chromogranin A and the Endothelial Barrier Function
Current Medicinal Chemistry <i>Ginkgo Biloba</i>: A Famous Living Fossil Tree and an Ancient Herbal Traditional Chinese Medicine
Current Nutrition & Food Science Mitochondria and the Pathophysiological Mechanism of Atrial Fibrillation
Current Pharmaceutical Design The Role of Fatty Acids in the Regulation of Cerebral Vascular Function and Neuroprotection in Ischemia
CNS & Neurological Disorders - Drug Targets Patent Selections
Recent Patents on Cardiovascular Drug Discovery RCAN1 Increases Aβ Generation by Promoting N-glycosylation via Oligosaccharyltransferase
Current Alzheimer Research Haptic Interfaces for Mobile Devices: A Survey of the State of the Art
Recent Patents on Computer Science Tracking Stem Cells for Cellular Therapy in Stroke
Current Pharmaceutical Design Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders
CNS & Neurological Disorders - Drug Targets Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine
Current Pharmacogenomics and Personalized Medicine Inflammatory Markers in Coronary Artery Disease: Pathophysiological Mechanisms, Prognostic and Therapeutic Implications
Current Cardiology Reviews Sodium Ion Transporters as New Therapeutic Targets in Heart Failure
Cardiovascular & Hematological Agents in Medicinal Chemistry Poly(ADP-Ribosyl)ation Enzyme-1 as a Target for Neuroprotection in Acute Central Nervous System Injury
Current Drug Targets - CNS & Neurological Disorders Efficacy and Safety of Antiplatelet Therapies in Symptomatic Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis
Current Vascular Pharmacology Current Therapeutic Strategies and Future Perspectives for the Treatment of Venous Thromboembolism
Current Pharmaceutical Design A Comprehensive Review on Therapeutic Potential of Chrysin in Brain Related Disorders
CNS & Neurological Disorders - Drug Targets Thrombus Extraction Catheters vs. Angiojet Rheolytic Thrombectomy in Thrombotic Lesions/SV Grafts
Current Cardiology Reviews Sliding Mode Control of an Actuated Knee Joint Orthosis
Current Signal Transduction Therapy Targeted Therapies for Autosomal Dominant Polycystic Kidney Disease
Current Medicinal Chemistry